Modern drug discovery mandates the rapid and modular assembly of increasingly complex substances. Medicinally relevant molecules overwhelmingly bear nitrogen functionality with 179 of the top 200 brand name drugs containing at least one N-atom. Increasingly, the nitrogen atom is not merely a functional substituent, such as a pendant amine or linking amide, but is present in the form of a heterocycle, often bearing stereocenters. The development of methods to access these heterocycles from easily accessible precursors is an attractive goal. The resultant heterocycles will facilitate the pace of drug discovery, with the common motifs visible in biologically active agents ranging from antibiotics, antidepressants as well as agonists and antagonists of protein-protein interactions such as Hsp40-Hsp70. The specific goals of this research are as follows: 1) develop temporary tethering strategies for [2+2+2] cycloadditions;2) Investigate the oxidative coupling of amides and alkene/alkyne ? systems to assemble piperidines by a catalyzed/oxidative protocol;3) Exploit readily available aza-dienes in metal-catalyzed [4+2] reactions;and 4) Implement isocyanate cycloadditions to involve allenes and vinyl cyclopropanes. The long-term impact of this science is to enable chemists to rapidly assemble complex structures with high efficiency.
One of the most significant barriers to health-related research involving small molecules is the rapid assembly of therapeutic agents. This proposal seeks to develop new methods to synthesize complex frameworks using easily accessible precursors with high efficiency.
|Piou, Tiffany; Romanov-Michailidis, Fedor; Romanova-Michaelides, Maria et al. (2017) Correlating Reactivity and Selectivity to Cyclopentadienyl Ligand Properties in Rh(III)-Catalyzed C-H Activation Reactions: An Experimental and Computational Study. J Am Chem Soc 139:1296-1310|
|Semakul, Natthawat; Jackson, Kelvin E; Paton, Robert S et al. (2017) Heptamethylindenyl (Ind*) enables diastereoselective benzamidation of cyclopropenes via Rh(iii)-catalyzed C-H activation. Chem Sci 8:1015-1020|
|Chu, John C K; Rovis, Tomislav (2016) Amide-directed photoredox-catalysed C-C bond formation at unactivated sp3 C-H bonds. Nature 539:272-275|
|Archambeau, Alexis; Rovis, Tomislav (2015) Rhodium(III)-Catalyzed Allylic C(sp(3))-H Activation of Alkenyl Sulfonamides: Unexpected Formation of Azabicycles. Angew Chem Int Ed Engl 54:13337-40|
|Zhang, Wen-Zhen; Chu, John C K; Oberg, Kevin M et al. (2015) Enantioselective rhodium-catalyzed isomerization of 4-iminocrotonates: asymmetric synthesis of a unique chiral synthon. J Am Chem Soc 137:553-5|
|Filloux, Claire M; Rovis, Tomislav (2015) Rh(I)-bisphosphine-catalyzed asymmetric, intermolecular hydroheteroarylation of ?-substituted acrylate derivatives. J Am Chem Soc 137:508-17|
|Romanov-Michailidis, Fedor; Sedillo, Kassandra F; Neely, Jamie M et al. (2015) Expedient Access to 2,3-Dihydropyridines from Unsaturated Oximes by Rh(III)-Catalyzed C-H Activation. J Am Chem Soc 137:8892-5|
|Davis, Tyler A; Wang, Chuanqi; Rovis, Tomislav (2015) Rhodium(III)-Catalyzed C-H Activation: An Oxidative Intramolecular Heck-Type Reaction Directed by a Carboxylic Acid. Synlett 26:1520-1524|
|Chu, John C K; Dalton, Derek M; Rovis, Tomislav (2015) Zn-catalyzed enantio- and diastereoselective formal [4 + 2] cycloaddition involving two electron-deficient partners: asymmetric synthesis of piperidines from 1-azadienes and nitro-alkenes. J Am Chem Soc 137:4445-52|
|Hyster, Todd K; Dalton, Derek M; Rovis, Tomislav (2015) Ligand Design for Rh(III)-Catalyzed C-H Activation: An Unsymmetrical Cyclopentadienyl Enables a Regioselective Synthesis of Dihydroisoquinolones. Chem Sci 6:254-258|
Showing the most recent 10 out of 41 publications